Data from FDA (Food and Drug Administration, USA) - Curated by EPG Health - Last updated 30 January 2017
CONTRAINDICATIONS Tyzine® Nasal Solution is contraindicated for patients who have shown previous hypersensitivity to its components.
The 0.1 % solution is contraindicated in children under six years of age.
Tyzine® Nasal Solution is not to be used for infants under two years of age.
Tyzine® Pediatric Nasal Drops (0.05 %) should be used for children between the ages of 2 and 6 years (See " Dosage and Administration ").
Tyzine® Nasal Solution should not be used by patients under treatment with Monoamine Oxidase (MAO) Inhibitors.
Occasionally, systemic sympathomimetic effects can occur, including
DOSAGE AND ADMINISTRATION Adults and Children 6 Years and Over Tyzine® 0.1 % Nasal Solution
Tyzine® 0.1 % Nasal Spray
Children 2 to 6 Years of Age Tyzine® 0.05 % Pediatric Nasal Drops Note:
|Date Last Revised||25-09-2013|
|Type||HUMAN PRESCRIPTION DRUG|
|Storage and handling||Recommended Storage Store below 86°F (30°C).|
|Marketing authorisation holder||PharmaDerm A division of Fougera Pharmaceuticals Inc.|